ClinicalTrials.Veeva

Menu

Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases (CADENCE)

A

AUM Cardiovascular

Status

Withdrawn

Conditions

Coronary Artery Disease

Treatments

Device: CADence System

Study type

Interventional

Funder types

Industry

Identifiers

NCT01584622
AUM1040-001

Details and patient eligibility

About

The purpose of the study is to evaluate the effectiveness of the CADence system, a non-invasive device, in detecting greater than or equal to 50% coronary stenosis anywhere in the coronary tree.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years old
  • Willing and able to give informed consent
  • Indicated for angiography evaluation.

Exclusion criteria

  • Pregnant or nursing
  • Presence of pacemaker/defibrillator
  • Presence of artificial valve
  • Presence of severe valve disease
  • Presence of congenital heart defect
  • Left Ventricular Assist Device (LVAD)
  • Presence of a bypass graft
  • Presence of scars on the site thorax areas
  • Coarctation of the aorta
  • Participation in trial within 30 days prior to collecting CADenceTM data
  • Asthma with wheezing
  • Inability to lie flat in the supine position
  • Acute STEMI
  • Heart Transplant
  • Recent Cocaine Use

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Double Blind

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems